Lin Shao-Lee

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lin Shao-Lee's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
314.71
Quantity 50,914 -28.1%
Value US$572,452
Transaction date
Sale
Price
75.80
Quantity 47,949 -42.2%
Value US$533,165
Transaction date
Sale
Price
41.65
Quantity 83,650 -44.7%
Value US$4,952,372
Transaction date
Proposed sale
Price
28.26
Quantity 18,258
Value US$515,971
Transaction date
Sale
Price
27.75
Quantity 5,775 -0.8%
Value US$160,256
Transaction date
Sale
Price
26.99
Quantity 34,225 -4.5%
Value US$923,733
Transaction date
Proposed sale
Price
27.01
Quantity 40,000
Value US$1,080,400
US ACELYRIN Inc (SLRN)
Transaction date
Sale
Price
6.63
Quantity 9,961 -0.6%
Value US$66,024
US ACELYRIN Inc (SLRN)
Transaction date
Sale
Price
7.60
Quantity 15,701 -1.0%
Value US$119,403
US ACELYRIN Inc (SLRN)
Transaction date
Planned sale
Price
7.41
Quantity 10,691 -0.7%
Value US$79,188
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-13
S Sale
50,914 -28.1%
314.71
US$572,452 		50,914 -28.1% 314.71 US$572,452
2026-08-14 2026-08-13
S Sale
47,949 -42.2%
75.80
US$533,165 		47,949 -42.2% 75.80 US$533,165
2026-08-14 2026-08-13
S Sale
83,650 -44.7%
41.65
US$4,952,372 		83,650 -44.7% 41.65 US$4,952,372
2026-08-14 2026-08-13
PrS Proposed sale
18,258
28.26
US$515,971 		18,258 28.26 US$515,971
2026-08-14 2026-08-12
S Sale
5,775 -0.8%
27.75
US$160,256 		5,775 -0.8% 27.75 US$160,256
2026-08-14 2026-08-12
S Sale
34,225 -4.5%
26.99
US$923,733 		34,225 -4.5% 26.99 US$923,733
2026-08-14 2026-08-12
PrS Proposed sale
40,000
27.01
US$1,080,400 		40,000 27.01 US$1,080,400
2024-04-03 2024-04-01
US ACELYRIN Inc (SLRN)
S Sale
9,961 -0.6%
6.63
US$66,024 		9,961 -0.6% 6.63 US$66,024
2024-02-22 2024-02-20
US ACELYRIN Inc (SLRN)
S Sale
15,701 -1.0%
7.60
US$119,403 		15,701 -1.0% 7.60 US$119,403
2024-01-04 2024-01-02
US ACELYRIN Inc (SLRN)
PlS Planned sale
10,691 -0.7%
7.41
US$79,188 		10,691 -0.7% 7.41 US$79,188